Sino Biological, which offers CRO services and specializes in recombinant protein production and antibody development, signed a lease with Hines, a global real estate investment, development, and property manager. The company began construction on its new Center for Bioprocessing (C4B) at the Levit Green facility in Houston, TX, its first U.S.-based biomanufacturing facility.
“We are extremely excited about our new partnership with the Hines team and our forthcoming laboratories and production facilities at Levit Green,” said Rob Burgess, PhD, Sino Biological’s chief business officer. “Hines is at the forefront of next-generation laboratory space design and development, and our new site at the Levit Green master-planned district in the heart of Houston’s Texas Medical Center will enable Sino Biological to considerably expand its research services and bioreagent manufacture capabilities into the United States.”
“I have assembled a world-class team which is currently establishing the C4B with the ultimate goal to promote the scientific development of next-gen precision medicine therapeutic antibodies and proteins,” added Yingmin Zhu, PhD, head of C4B.
